Research graph
References from Reconocimiento precoz de la enfermedad pulmonar intersticial fibrosante: recomendaciones prácticas para la evaluación inicial y derivación. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1164/ajrccm.165.2.ats01
10.1164/ajrccm.165.2.ats01 · 2002 · External reference
Time to diagnosis of idiopathic pulmonary fibrosis in the IPF-PRO registry
2020 · External reference
Idiopathic pulmonary fibrosis: physician and patient perspectives on the pathway to care from symptom recognition to diagnosis and disease burden
10.1111/resp.14154 · 2022 · External reference
Barriers to timely diagnosis of interstitial lung disease in the real world: the INTENSITY survey
10.1186/s12890-017-0560-x · 2018 · External reference
Early diagnosis and treatment of idiopathic pulmonary fibrosis: a narrative review
10.1007/s41030-023-00216-0 · 2023 · External reference
Idiopathic pulmonary fibrosis in the United States: time to diagnosis and treatment
10.1186/s12890-023-02565-7 · 2023 · External reference
An open-label study of the long-term safety of pirfenidone in patients with idiopathic pulmonary fibrosis (RECAP)
10.1159/000479976 · 2017 · External reference
Diagnostic delay in IPF impacts progression-free survival, quality of life and hospitalisation rates
2022 · External reference
A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis
10.1056/nejmoa1402582 · 2014 · External reference
Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis
10.1056/nejmoa1402584 · 2014 · External reference
Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS/ERS/JRS/ALAT clinical practice guideline
10.1164/rccm.202202-0399st · 2022 · External reference
Unresolved reference
2013 · External reference
Clinical course and prediction of survival in idiopathic pulmonary fibrosis
10.1164/rccm.201006-0894ci · 2011 · External reference
Drug induced interstitial lung disease
10.2174/1874306401206010063 · 2012 · External reference
Drug-induced interstitial lung disease
10.1183/13993003.02776-2021 · 2022 · External reference
The diagnostic pathway for patients with interstitial lung disease: a mixed-methods study of patients and physicians
2024 · External reference
The interstitial lung disease patient pathway: from referral to diagnosis
10.1183/23120541.00899-2024 · 2025 · External reference
Characterising patient pathways prior to the diagnosis of interstitial lung disease
10.1002/resp.70230 · 2026 · External reference
Velcro crackles: the key for early diagnosis of idiopathic pulmonary fibrosis?
10.1183/09031936.00001612 · 2012 · External reference
”Velcro-type” crackles predict specific radiologic features of fibrotic interstitial lung disease
10.1186/s12890-018-0670-0 · 2018 · External reference
Diagnostic test interpretation and referral delay in patients with interstitial lung disease
10.1186/s12931-019-1228-2 · 2019 · External reference
Disease progression in idiopathic pulmonary fibrosis without pulmonary function impairment
10.1111/resp.12082 · 2013 · External reference
Disease progression in idiopathic pulmonary fibrosis with mild physiological impairment: analysis from the Australian IPF registry
10.1186/s12890-018-0575-y · 2018 · External reference
Delayed access and survival in idiopathic pulmonary fibrosis: a cohort study
10.1164/rccm.201104-0668oc · 2011 · External reference
Early diagnosis of fibrotic interstitial lung disease: challenges and opportunities
10.1016/s2213-2600(21)00017-5 · 2021 · External reference
The earlier, the better: impact of early diagnosis on clinical outcome in idiopathic pulmonary fibrosis
10.1016/j.pupt.2017.02.005 · 2017 · External reference
Antifibrotic therapy and outcomes in idiopathic pulmonary fibrosis: real-world insights from the INSIGHTS-IPF registry
2020 · External reference
Multidisciplinary teams in the clinical care of fibrotic interstitial lung disease: current perspectives
10.1183/16000617.0003-2022 · 2022 · External reference
Multicentre evaluation of multidisciplinary team meeting agreement on diagnosis in diffuse parenchymal lung disease: a case-cohort study
10.1016/s2213-2600(16)30033-9 · 2016 · External reference
Regional medical collaboration may lead to early detection of interstitial lung disease
10.3390/jcm14175923 · 2025 · External reference
Role of a regional multidisciplinary conference in the diagnosis of interstitial lung disease
10.1513/annalsats.201811-794oc · 2019 · External reference
Clinical impact of the interstitial lung disease multidisciplinary service
10.1111/resp.12850 · 2016 · External reference
Diagnostic ability of a dynamic multidisciplinary discussion in interstitial lung diseases: a retrospective observational study of 938 cases
10.1016/j.chest.2018.03.026 · 2018 · External reference
Can a virtual multi-centre multidisciplinary discussion improve the diagnosis and management of interstitial lung disease? A retrospective cohort study across multiple institutions
10.1136/bmjopen-2024-098549 · 2025 · External reference
Virtual multidisciplinary discussion across borders for interstitial lung disease: a prospective multicentre study
10.1136/bmjopen-2025-110693 · 2025 · External reference
The benefits of a rapid diagnostic primary care circuit for interstitial lung disease
10.1038/s41533-025-00462-6 · 2025 · External reference
